TRANSCEND-T2D-1: Diabetes-Specific Phase 3 Data (June 2026) Separate from the TRIUMPH obesity program, Eli Lilly runs TRANSCEND-T2D a dedicated Phase 3 program for type 2 diabetes
A few other states are planning or considering obesity drug restrictions in state fiscal year 2026 or 2027, and state interest in expanding coverage of obesity drugs is also waning according to this years survey, with states continuing to report cost as the key factor contributing to obesity drug coverage decisions
Back in 2024, research presented at the European Congress on Obesity found that people who gradually reduced their GLP-1s dose to zero over the course of nine weeks were able to maintain a stable body weight in the first 26 weeks post-GLP-1s
And if there is family planning, that the medication should be stopped at least two months prior to removing contraception or trying to conceive. Log in below to join the conversation.
this is the best product yet i have tried for testosterone lean mass & strength yet Bought this 2 weeks ago stacked with adrenalize have lost 6 pounds and gained muscle mass For the past two years now I have been an avid workout warrior and watch what I eat a majority of the time
Impact of surgically induced weight loss on cardiovascular autonomic function: one-year follow-up
